The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation
Objectives: To assess the clinical effectiveness and cost-effectiveness of topotecan as second-line treatment for small cell lung cancer (SCLC). Data sources: Bibliographic databases were searched from 1990 to February 2009, including the Cochrane library, MEDLINE (Ovid), EMBASE (Ovid), PREMEDLINE...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2010-03.
|
Subjects: | |
Online Access: | Get fulltext Get fulltext |